MedTrace Logo

Collect and Assess Tissue Samples From Subjects With Hematologic Malignancy

NCT04014764 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 119

Last updated 2022-04-05

No results posted yet for this study

Summary

This is a prospective, multicenter observational study to collect clinically annotated biospecimens in order to assess the correlation between ex vivo data generated by the Notable assay platform and clinical outcome.

Conditions

Interventions

OTHER

This is a non-interventional study

N/A. This is a non-interventional study. Following consent, the subject will have biospecimen samples taken during routine standard of care procedures, and provided to Sponsor for analysis. Optional research blood draws may occur at treating physician's discretion to obtain additional tissue samples.

Sponsors & Collaborators

  • Notable Labs

    lead INDUSTRY

Principal Investigators

  • Hiroomi Tada, MD, Ph.D. · Notable Labs

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-15
Primary Completion
2022-03-31
Completion
2022-03-31

Countries

  • United States
  • Greece
  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04014764 on ClinicalTrials.gov